Improvement in overall survival with carfilzomib, lenalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma - Siegel, David S.; Dimopoulos, Meletios A.; Ludwig, Heinz; Facon, Thierry; Goldschmidt, Hartmut; Jakubowiak, Andrzej; San-Miguel, Jesus; Obreja, Mihaela; Blaedel, Julie; Stewart, A. Keith (Journal of clinical oncology, 2018)
Gesehen am 01.10.2019